VistaGen Therapeutics Inc. (NASDAQ: VTGN) CEO Discusses ‘Game-Changing’ Potential of Drug Pipeline Lineup in Stock2Me Podcast
VTGN is committed to developing and commercializing differentiated new generation medications that go beyond the current standard of care for…